Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 42 entries
Sorted by: Best Match Show Resources per page
Coordination chemistry of phosphinocarbynes: phosphorus vs. carbyne site selectivity.

Dalton transactions (Cambridge, England : 2003)

Colebatch AL, Hill AF.
PMID: 28287661
Dalton Trans. 2017 Mar 27;46(13):4355-4365. doi: 10.1039/c6dt04770j.

The phosphinocarbyne complex [W([triple bond, length as m-dash]CPPh

Cite
Colebatch AL, Hill AF. Coordination chemistry of phosphinocarbynes: phosphorus vs. carbyne site selectivity. Dalton Trans. 2017;46(13):4355-4365doi: 10.1039/c6dt04770j.
Colebatch, A. L., & Hill, A. F. (2017). Coordination chemistry of phosphinocarbynes: phosphorus vs. carbyne site selectivity. Dalton transactions (Cambridge, England : 2003), 46(13), 4355-4365. https://doi.org/10.1039/c6dt04770j
Colebatch, Annie L, and Hill, Anthony F. "Coordination chemistry of phosphinocarbynes: phosphorus vs. carbyne site selectivity." Dalton transactions (Cambridge, England : 2003) vol. 46,13 (2017): 4355-4365. doi: https://doi.org/10.1039/c6dt04770j
Colebatch AL, Hill AF. Coordination chemistry of phosphinocarbynes: phosphorus vs. carbyne site selectivity. Dalton Trans. 2017 Mar 27;46(13):4355-4365. doi: 10.1039/c6dt04770j. PMID: 28287661.
Copy Download .nbib Format: NLM
Amine-Borane Dehydropolymerization: Challenges and Opportunities.

Chemistry (Weinheim an der Bergstrasse, Germany)

Colebatch AL, Weller AS.
PMID: 30338876
Chemistry. 2019 Jan 28;25(6):1379-1390. doi: 10.1002/chem.201804592. Epub 2018 Dec 27.

The dehydropolymerization of amine-boranes, exemplified as H

Cite
Colebatch AL, Weller AS. Amine-Borane Dehydropolymerization: Challenges and Opportunities. Chemistry. 2018;25(6):1379-1390doi: 10.1002/chem.201804592.
Colebatch, A. L., & Weller, A. S. (2019). Amine-Borane Dehydropolymerization: Challenges and Opportunities. Chemistry (Weinheim an der Bergstrasse, Germany), 25(6), 1379-1390. https://doi.org/10.1002/chem.201804592
Colebatch, Annie L, and Weller, Andrew S. "Amine-Borane Dehydropolymerization: Challenges and Opportunities." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 25,6 (2019): 1379-1390. doi: https://doi.org/10.1002/chem.201804592
Colebatch AL, Weller AS. Amine-Borane Dehydropolymerization: Challenges and Opportunities. Chemistry. 2019 Jan 28;25(6):1379-1390. doi: 10.1002/chem.201804592. Epub 2018 Dec 27. PMID: 30338876; PMCID: PMC6391989.
Copy Download .nbib Format: NLM
How Changing the Bridgehead Can Affect the Properties of Tripodal Ligands.

Angewandte Chemie (International ed. in English)

Plajer AJ, Colebatch AL, Rizzuto FJ, Pröhm P, Bond AD, García-Rodríguez R, Wright DS.
PMID: 29603844
Angew Chem Int Ed Engl. 2018 May 28;57(22):6648-6652. doi: 10.1002/anie.201802350. Epub 2018 Apr 27.

Although a multitude of studies have explored the coordination chemistry of classical tripodal ligands containing a range of main-group bridgehead atoms or groups, it is not clear how periodic trends affect ligand character and reactivity within a single ligand...

Cite
Plajer AJ, Colebatch AL, Rizzuto FJ, et al. How Changing the Bridgehead Can Affect the Properties of Tripodal Ligands. Angew Chem Int Ed Engl. 2018;57(22):6648-6652doi: 10.1002/anie.201802350.
Plajer, A. J., Colebatch, A. L., Rizzuto, F. J., Pröhm, P., Bond, A. D., García-Rodríguez, R., & Wright, D. S. (2018). How Changing the Bridgehead Can Affect the Properties of Tripodal Ligands. Angewandte Chemie (International ed. in English), 57(22), 6648-6652. https://doi.org/10.1002/anie.201802350
Plajer, Alex J, et al. "How Changing the Bridgehead Can Affect the Properties of Tripodal Ligands." Angewandte Chemie (International ed. in English) vol. 57,22 (2018): 6648-6652. doi: https://doi.org/10.1002/anie.201802350
Plajer AJ, Colebatch AL, Rizzuto FJ, Pröhm P, Bond AD, García-Rodríguez R, Wright DS. How Changing the Bridgehead Can Affect the Properties of Tripodal Ligands. Angew Chem Int Ed Engl. 2018 May 28;57(22):6648-6652. doi: 10.1002/anie.201802350. Epub 2018 Apr 27. PMID: 29603844.
Copy Download .nbib Format: NLM
Non-invasive recording from the human cerebellum during a classical conditioning paradigm using the otolith-evoked blink reflex.

Neuroscience letters

Todd NPM, Govender S, Colebatch JG.
PMID: 34582972
Neurosci Lett. 2021 Nov 20;765:136270. doi: 10.1016/j.neulet.2021.136270. Epub 2021 Sep 25.

We studied nine normal volunteers with a classical conditioning paradigm using a mastoid tap, believed to activate otolith receptors, as an unconditional stimulus (US) and the consequent blink as the unconditioned response (UR). Both visual (alternation of stripes) and...

Cite
Todd NPM, Govender S, Colebatch JG. Non-invasive recording from the human cerebellum during a classical conditioning paradigm using the otolith-evoked blink reflex. Neurosci Lett. 2021;765:136270doi: 10.1016/j.neulet.2021.136270.
Todd, N. P. M., Govender, S., & Colebatch, J. G. (2021). Non-invasive recording from the human cerebellum during a classical conditioning paradigm using the otolith-evoked blink reflex. Neuroscience letters, 765136270. https://doi.org/10.1016/j.neulet.2021.136270
Todd, Neil P M, et al. "Non-invasive recording from the human cerebellum during a classical conditioning paradigm using the otolith-evoked blink reflex." Neuroscience letters vol. 765 (2021): 136270. doi: https://doi.org/10.1016/j.neulet.2021.136270
Todd NPM, Govender S, Colebatch JG. Non-invasive recording from the human cerebellum during a classical conditioning paradigm using the otolith-evoked blink reflex. Neurosci Lett. 2021 Nov 20;765:136270. doi: 10.1016/j.neulet.2021.136270. Epub 2021 Sep 25. PMID: 34582972.
Copy Download .nbib Format: NLM
ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1.

Pathology

Fielder T, Butler J, Tierney G, Holmes M, Lam KY, Satgunaseelan L, Colebatch AJ, Mahar A, Gupta R, O'Toole S, Cooper WA.
PMID: 34702583
Pathology. 2021 Oct 23; doi: 10.1016/j.pathol.2021.07.012. Epub 2021 Oct 23.

A small subset of lung adenocarcinomas harbour ROS1 gene arrangements and are amenable to tyrosine kinase inhibitor therapy. Current practice in Australia involves screening for ROS1 rearrangements in adenocarcinomas using ROS1 immunohistochemistry (IHC) followed by confirmatory molecular testing such...

Cite
Fielder T, Butler J, Tierney G, et al. ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1. Pathology. 2021;doi: 10.1016/j.pathol.2021.07.012.
Fielder, T., Butler, J., Tierney, G., Holmes, M., Lam, K. Y., Satgunaseelan, L., Colebatch, A. J., Mahar, A., Gupta, R., O'Toole, S., & Cooper, W. A. (2021). ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1. Pathology, . https://doi.org/10.1016/j.pathol.2021.07.012
Fielder, Timothy, et al. "ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1." Pathology vol. (2021). doi: https://doi.org/10.1016/j.pathol.2021.07.012
Fielder T, Butler J, Tierney G, Holmes M, Lam KY, Satgunaseelan L, Colebatch AJ, Mahar A, Gupta R, O'Toole S, Cooper WA. ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1. Pathology. 2021 Oct 23; doi: 10.1016/j.pathol.2021.07.012. Epub 2021 Oct 23. PMID: 34702583.
Copy Download .nbib Format: NLM
Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children.

Pediatric dermatology

Haefliger S, Guitera P, Melhoranse Gouveia B, Colebatch AJ, Scolyer RA, Rtshiladze M, Martin LK.
PMID: 34738265
Pediatr Dermatol. 2021 Nov;38(6):1549-1552. doi: 10.1111/pde.14846. Epub 2021 Nov 04.

A 3.5-month-old boy presented with a changing medium-sized congenital melanocytic nevus on his leg. Due to atypical features on dermoscopy and reflectance confocal microscopy (RCM), an excision of the area of concern was performed. Histopathology showed many of the...

Cite
Haefliger S, Guitera P, Melhoranse Gouveia B, et al. Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children. Pediatr Dermatol. 2021;38(6):1549-1552doi: 10.1111/pde.14846.
Haefliger, S., Guitera, P., Melhoranse Gouveia, B., Colebatch, A. J., Scolyer, R. A., Rtshiladze, M., & Martin, L. K. (2021). Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children. Pediatric dermatology, 38(6), 1549-1552. https://doi.org/10.1111/pde.14846
Haefliger, Stefanie, et al. "Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children." Pediatric dermatology vol. 38,6 (2021): 1549-1552. doi: https://doi.org/10.1111/pde.14846
Haefliger S, Guitera P, Melhoranse Gouveia B, Colebatch AJ, Scolyer RA, Rtshiladze M, Martin LK. Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children. Pediatr Dermatol. 2021 Nov;38(6):1549-1552. doi: 10.1111/pde.14846. Epub 2021 Nov 04. PMID: 34738265.
Copy Download .nbib Format: NLM
Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children.

Pediatric dermatology

Haefliger S, Guitera P, Melhoranse Gouveia B, Colebatch AJ, Scolyer RA, Rtshiladze M, Martin LK.
PMID: 34738265
Pediatr Dermatol. 2021 Nov 04; doi: 10.1111/pde.14846. Epub 2021 Nov 04.

A 3.5-month-old boy presented with a changing medium-sized congenital melanocytic nevus on his leg. Due to atypical features on dermoscopy and reflectance confocal microscopy (RCM), an excision of the area of concern was performed. Histopathology showed many of the...

Cite
Haefliger S, Guitera P, Melhoranse Gouveia B, et al. Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children. Pediatr Dermatol. 2021;doi: 10.1111/pde.14846.
Haefliger, S., Guitera, P., Melhoranse Gouveia, B., Colebatch, A. J., Scolyer, R. A., Rtshiladze, M., & Martin, L. K. (2021). Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children. Pediatric dermatology, . https://doi.org/10.1111/pde.14846
Haefliger, Stefanie, et al. "Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children." Pediatric dermatology vol. (2021). doi: https://doi.org/10.1111/pde.14846
Haefliger S, Guitera P, Melhoranse Gouveia B, Colebatch AJ, Scolyer RA, Rtshiladze M, Martin LK. Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children. Pediatr Dermatol. 2021 Nov 04; doi: 10.1111/pde.14846. Epub 2021 Nov 04. PMID: 34738265.
Copy Download .nbib Format: NLM
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.

Pathology

Scolyer RA, Atkinson V, Gyorki DE, Lambie D, O'Toole S, Saw RPM, Amanuel B, Angel CM, Button-Sloan AE, Carlino MS, Ch'ng S, Colebatch AJ, Daneshvar D, Pires da Silva I, Dawson T, Ferguson PM, Foster-Smith E, Fox SB, Gill AJ, Gupta R, Henderson MA, Hong AM, Howle JR, Jackett LA, James C, Lee CS, Lochhead A, Loh D, McArthur GA, McLean CA, Menzies AM, Nieweg OE, O'Brien BH, Pennington TE, Potter AJ, Prakash S, Rawson RV, Read RL, Rtshiladze MA, Shannon KF, Smithers BM, Spillane AJ, Stretch JR, Thompson JF, Tucker P, Varey AHR, Vilain RE, Wood BA, Long GV.
PMID: 34937664
Pathology. 2021 Dec 19; doi: 10.1016/j.pathol.2021.11.002. Epub 2021 Dec 19.

Targeted therapy (BRAF inhibitor plus MEK inhibitor) is now among the possible treatment options for patients with BRAF mutation-positive stage III or stage IV melanoma. This makes prompt BRAF mutation testing an important step in the management of patients...

Cite
Scolyer RA, Atkinson V, Gyorki DE, et al. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting. Pathology. 2021;doi: 10.1016/j.pathol.2021.11.002.
Scolyer, R. A., Atkinson, V., Gyorki, D. E., Lambie, D., O'Toole, S., Saw, R. P. M., Amanuel, B., Angel, C. M., Button-Sloan, A. E., Carlino, M. S., Ch'ng, S., Colebatch, A. J., Daneshvar, D., Pires da Silva, I., Dawson, T., Ferguson, P. M., Foster-Smith, E., Fox, S. B., Gill, A. J., Gupta, R., Henderson, M. A., Hong, A. M., Howle, J. R., Jackett, L. A., James, C., Lee, C. S., Lochhead, A., Loh, D., McArthur, G. A., McLean, C. A., Menzies, A. M., Nieweg, O. E., O'Brien, B. H., Pennington, T. E., Potter, A. J., Prakash, S., Rawson, R. V., Read, R. L., Rtshiladze, M. A., Shannon, K. F., Smithers, B. M., Spillane, A. J., Stretch, J. R., Thompson, J. F., Tucker, P., Varey, A. H. R., Vilain, R. E., Wood, B. A., & Long, G. V. (2021). BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting. Pathology, . https://doi.org/10.1016/j.pathol.2021.11.002
Scolyer, Richard A, et al. "BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting." Pathology vol. (2021). doi: https://doi.org/10.1016/j.pathol.2021.11.002
Scolyer RA, Atkinson V, Gyorki DE, Lambie D, O'Toole S, Saw RPM, Amanuel B, Angel CM, Button-Sloan AE, Carlino MS, Ch'ng S, Colebatch AJ, Daneshvar D, Pires da Silva I, Dawson T, Ferguson PM, Foster-Smith E, Fox SB, Gill AJ, Gupta R, Henderson MA, Hong AM, Howle JR, Jackett LA, James C, Lee CS, Lochhead A, Loh D, McArthur GA, McLean CA, Menzies AM, Nieweg OE, O'Brien BH, Pennington TE, Potter AJ, Prakash S, Rawson RV, Read RL, Rtshiladze MA, Shannon KF, Smithers BM, Spillane AJ, Stretch JR, Thompson JF, Tucker P, Varey AHR, Vilain RE, Wood BA, Long GV. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting. Pathology. 2021 Dec 19; doi: 10.1016/j.pathol.2021.11.002. Epub 2021 Dec 19. PMID: 34937664.
Copy Download .nbib Format: NLM
Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence.

Nature cancer

Pruessmann W, Rytlewski J, Wilmott J, Mihm MC, Attrill GH, Dyring-Andersen B, Fields P, Zhan Q, Colebatch AJ, Ferguson PM, Thompson JF, Kallenbach K, Yusko E, Clark RA, Robins H, Scolyer RA, Kupper TS.
PMID: 33305293
Nat Cancer. 2020 Feb;1(2):197-209. doi: 10.1038/s43018-019-0019-5. Epub 2020 Jan 20.

Primary melanomas >1 mm thickness are potentially curable by resection, but can recur metastatically. We assessed the prognostic value of T cell fraction (TCFr) and repertoire T cell clonality, measured by high-throughput-sequencing of the T cell receptor beta chain...

Cite
Pruessmann W, Rytlewski J, Wilmott J, et al. Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nat Cancer. 2020;1(2):197-209doi: 10.1038/s43018-019-0019-5.
Pruessmann, W., Rytlewski, J., Wilmott, J., Mihm, M. C., Attrill, G. H., Dyring-Andersen, B., Fields, P., Zhan, Q., Colebatch, A. J., Ferguson, P. M., Thompson, J. F., Kallenbach, K., Yusko, E., Clark, R. A., Robins, H., Scolyer, R. A., & Kupper, T. S. (2020). Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nature cancer, 1(2), 197-209. https://doi.org/10.1038/s43018-019-0019-5
Pruessmann, Wiebke, et al. "Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence." Nature cancer vol. 1,2 (2020): 197-209. doi: https://doi.org/10.1038/s43018-019-0019-5
Pruessmann W, Rytlewski J, Wilmott J, Mihm MC, Attrill GH, Dyring-Andersen B, Fields P, Zhan Q, Colebatch AJ, Ferguson PM, Thompson JF, Kallenbach K, Yusko E, Clark RA, Robins H, Scolyer RA, Kupper TS. Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nat Cancer. 2020 Feb;1(2):197-209. doi: 10.1038/s43018-019-0019-5. Epub 2020 Jan 20. PMID: 33305293; PMCID: PMC7725220.
Copy Download .nbib Format: NLM
Non-invasive recording from the human cerebellum during a classical conditioning paradigm using the otolith-evoked blink reflex.

Neuroscience letters

Todd NPM, Govender S, Colebatch JG.
PMID: 34582972
Neurosci Lett. 2021 Nov 20;765:136270. doi: 10.1016/j.neulet.2021.136270. Epub 2021 Sep 25.

We studied nine normal volunteers with a classical conditioning paradigm using a mastoid tap, believed to activate otolith receptors, as an unconditional stimulus (US) and the consequent blink as the unconditioned response (UR). Both visual (alternation of stripes) and...

Cite
Todd NPM, Govender S, Colebatch JG. Non-invasive recording from the human cerebellum during a classical conditioning paradigm using the otolith-evoked blink reflex. Neurosci Lett. 2021;765:136270doi: 10.1016/j.neulet.2021.136270.
Todd, N. P. M., Govender, S., & Colebatch, J. G. (2021). Non-invasive recording from the human cerebellum during a classical conditioning paradigm using the otolith-evoked blink reflex. Neuroscience letters, 765136270. https://doi.org/10.1016/j.neulet.2021.136270
Todd, Neil P M, et al. "Non-invasive recording from the human cerebellum during a classical conditioning paradigm using the otolith-evoked blink reflex." Neuroscience letters vol. 765 (2021): 136270. doi: https://doi.org/10.1016/j.neulet.2021.136270
Todd NPM, Govender S, Colebatch JG. Non-invasive recording from the human cerebellum during a classical conditioning paradigm using the otolith-evoked blink reflex. Neurosci Lett. 2021 Nov 20;765:136270. doi: 10.1016/j.neulet.2021.136270. Epub 2021 Sep 25. PMID: 34582972.
Copy Download .nbib Format: NLM
Rearrangement of bis(alkylidynyl)phosphines to phospha-acyls.

Chemical communications (Cambridge, England)

Colebatch AL, Han YS, Hill AF, Sharma M, Shang R, Ward JS.
PMID: 28111645
Chem Commun (Camb). 2017 Feb 07;53(11):1832-1835. doi: 10.1039/c6cc09764b. Epub 2017 Jan 23.

A range of bis(alkylidynyl)phosphines RP{C[triple bond, length as m-dash]M(CO)

Cite
Colebatch AL, Han YS, Hill AF, et al. Rearrangement of bis(alkylidynyl)phosphines to phospha-acyls. Chem Commun (Camb). 2017;53(11):1832-1835doi: 10.1039/c6cc09764b.
Colebatch, A. L., Han, Y. S., Hill, A. F., Sharma, M., Shang, R., & Ward, J. S. (2017). Rearrangement of bis(alkylidynyl)phosphines to phospha-acyls. Chemical communications (Cambridge, England), 53(11), 1832-1835. https://doi.org/10.1039/c6cc09764b
Colebatch, Annie L, et al. "Rearrangement of bis(alkylidynyl)phosphines to phospha-acyls." Chemical communications (Cambridge, England) vol. 53,11 (2017): 1832-1835. doi: https://doi.org/10.1039/c6cc09764b
Colebatch AL, Han YS, Hill AF, Sharma M, Shang R, Ward JS. Rearrangement of bis(alkylidynyl)phosphines to phospha-acyls. Chem Commun (Camb). 2017 Feb 07;53(11):1832-1835. doi: 10.1039/c6cc09764b. Epub 2017 Jan 23. PMID: 28111645.
Copy Download .nbib Format: NLM
Iron Precatalysts with Bulky Tri(tert-butyl)cyclopentadienyl Ligands for the Dehydrocoupling of Dimethylamine-Borane.

Chemistry (Weinheim an der Bergstrasse, Germany)

Turner J, Chilton NF, Kumar A, Colebatch AL, Whittell GR, Sparkes HA, Weller AS, Manners I.
PMID: 29573487
Chemistry. 2018 Sep 20;24(53):14127-14136. doi: 10.1002/chem.201705316. Epub 2018 Aug 24.

In an attempt to prepare new Fe catalysts for the dehydrocoupling of amine-boranes and to provide mechanistic insight, the paramagnetic Fe

Cite
Turner J, Chilton NF, Kumar A, et al. Iron Precatalysts with Bulky Tri(tert-butyl)cyclopentadienyl Ligands for the Dehydrocoupling of Dimethylamine-Borane. Chemistry. 2018;24(53):14127-14136doi: 10.1002/chem.201705316.
Turner, J., Chilton, N. F., Kumar, A., Colebatch, A. L., Whittell, G. R., Sparkes, H. A., Weller, A. S., & Manners, I. (2018). Iron Precatalysts with Bulky Tri(tert-butyl)cyclopentadienyl Ligands for the Dehydrocoupling of Dimethylamine-Borane. Chemistry (Weinheim an der Bergstrasse, Germany), 24(53), 14127-14136. https://doi.org/10.1002/chem.201705316
Turner, Joshua, et al. "Iron Precatalysts with Bulky Tri(tert-butyl)cyclopentadienyl Ligands for the Dehydrocoupling of Dimethylamine-Borane." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 24,53 (2018): 14127-14136. doi: https://doi.org/10.1002/chem.201705316
Turner J, Chilton NF, Kumar A, Colebatch AL, Whittell GR, Sparkes HA, Weller AS, Manners I. Iron Precatalysts with Bulky Tri(tert-butyl)cyclopentadienyl Ligands for the Dehydrocoupling of Dimethylamine-Borane. Chemistry. 2018 Sep 20;24(53):14127-14136. doi: 10.1002/chem.201705316. Epub 2018 Aug 24. PMID: 29573487.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 42 entries